Verona Pharma Plc Overview

Verona Pharma Plc EBIT

EBIT (Earnings Before Interest and Taxes) analysis for VRNA.

Quarterly EBIT

$18.70M

↑ 126.03% YoY

As of Jun 30, 2025

Annual EBIT (TTM)

-$110.82M

↑ 16.79% YoY

Trailing 12 months ending Jun 30, 2025

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin